Literature DB >> 16786507

A quality assessment survey of SNP genotyping laboratories.

Päivi Lahermo1, Ulrika Liljedahl, Grethe Alnaes, Tomas Axelsson, Anthony J Brookes, Pekka Ellonen, Per-Henrik Groop, Christer Halldén, Dan Holmberg, Kristina Holmberg, Mauri Keinänen, Katrin Kepp, Juha Kere, Päivi Kiviluoma, Vessela Kristensen, Cecilia Lindgren, Jacob Odeberg, Pia Osterman, Maija Parkkonen, Janna Saarela, Maria Sterner, Linda Strömqvist, Ulvi Talas, Maija Wessman, Aarno Palotie, Ann-Christine Syvänen.   

Abstract

To survey the quality of SNP genotyping, a joint Nordic quality assessment (QA) round was organized between 11 laboratories in the Nordic and Baltic countries. The QA round involved blinded genotyping of 47 DNA samples for 18 or six randomly selected SNPs. The methods used by the participating laboratories included all major platforms for small- to medium-size SNP genotyping. The laboratories used their standard procedures for SNP assay design, genotyping, and quality control. Based on the joint results from all laboratories, a consensus genotype for each DNA sample and SNP was determined by the coordinator of the survey, and the results from each laboratory were compared to this genotype. The overall genotyping accuracy achieved in the survey was excellent. Six laboratories delivered genotype data that were in full agreement with the consensus genotype. The average accuracy per SNP varied from 99.1 to 100% between the laboratories, and it was frequently 100% for the majority of the assays for which SNP genotypes were reported. Lessons from the survey are that special attention should be given to the quality of the DNA samples prior to genotyping, and that a conservative approach for calling the genotypes should be used to achieve a high accuracy. Copyright 2006 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2006        PMID: 16786507     DOI: 10.1002/humu.20346

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  8 in total

1.  CRY1, CRY2 and PRKCDBP genetic variants in metabolic syndrome.

Authors:  Leena Kovanen; Kati Donner; Mari Kaunisto; Timo Partonen
Journal:  Hypertens Res       Date:  2014-11-13       Impact factor: 3.872

2.  Effect of catechol-o-methyltransferase-gene (COMT) variants on experimental and acute postoperative pain in 1,000 women undergoing surgery for breast cancer.

Authors:  Oleg Kambur; Mari A Kaunisto; Emmi Tikkanen; Suzanne M Leal; Samuli Ripatti; Eija A Kalso
Journal:  Anesthesiology       Date:  2013-12       Impact factor: 7.892

3.  CRY2 genetic variants associate with dysthymia.

Authors:  Leena Kovanen; Mari Kaunisto; Kati Donner; Sirkku T Saarikoski; Timo Partonen
Journal:  PLoS One       Date:  2013-08-08       Impact factor: 3.240

4.  Genetic variants in SERPINA4 and SERPINA5, but not BCL2 and SIK3 are associated with acute kidney injury in critically ill patients with septic shock.

Authors:  Laura M Vilander; Mari A Kaunisto; Suvi T Vaara; Ville Pettilä
Journal:  Crit Care       Date:  2017-03-08       Impact factor: 9.097

5.  A comparison of simple sequence repeat and single nucleotide polymorphism marker technologies for the genotypic analysis of maize (Zea mays L.).

Authors:  E S Jones; H Sullivan; D Bhattramakki; J S C Smith
Journal:  Theor Appl Genet       Date:  2007-05-22       Impact factor: 5.574

6.  Robust SNP genotyping by multiplex PCR and arrayed primer extension.

Authors:  Mohua Podder; Jian Ruan; Ben W Tripp; Zane E Chu; Scott J Tebbutt
Journal:  BMC Med Genomics       Date:  2008-01-31       Impact factor: 3.063

7.  Development of a single tube 640-plex genotyping method for detection of nucleic acid variations on microarrays.

Authors:  Kaarel Krjutskov; Reidar Andreson; Reedik Mägi; Tiit Nikopensius; Andrey Khrunin; Evelin Mihailov; Veronika Tammekivi; Helena Sork; Maido Remm; Andres Metspalu
Journal:  Nucleic Acids Res       Date:  2008-06-05       Impact factor: 16.971

8.  SIRT1 Polymorphisms Associate with Seasonal Weight Variation, Depressive Disorders, and Diastolic Blood Pressure in the General Population.

Authors:  Leena Kovanen; Kati Donner; Timo Partonen
Journal:  PLoS One       Date:  2015-10-28       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.